Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis

被引:0
|
作者
Mcneely, Heidi L. [1 ]
Schreiber, Terri L. [1 ]
Swann, William L. [1 ,2 ]
Amura, Claudia R. [3 ]
机构
[1] Schreiber Res Grp, POB 371342, Denver, CO 80237 USA
[2] Univ Nebraska Omaha, Coll Publ Affairs & Community Serv, Sch Publ Adm, 6001 Dodge St,CPACS 111, Omaha, NE 68182 USA
[3] Univ Colorado, Coll Nursing, Anschutz Med Campus,13120 East 19th Ave,3rd Floor, Aurora, CO 80045 USA
关键词
Medications for opioid use disorder; Substance use disorder treatment; Jail-based services; Correctional health; RELEASE; PRISON; DEATH;
D O I
10.1186/s40352-024-00280-x
中图分类号
DF [法律]; D9 [法律];
学科分类号
0301 ;
摘要
Background Opioid use disorder (OUD) is common among individuals who are incarcerated. However, OUD treatment services are sparse in smaller county jails found in many rural areas, which limits a healthy and supportive jail environment. This study assesses the facilitators of and barriers to medications for opioid use disorder (MOUD) adoption or expansion in rural Colorado jails. A qualitative descriptive design was implemented during the summer of 2022 using semi-structured interviews with jail staff, sheriffs, and contracted personnel. Interview questions focused on facilitators of existing MOUD services and barriers to adopting or expanding services. To identify the facilitators and barriers, data were coded using thematic analysis.Results Seven jails were included in the study. Representatives from each jail participated in the seven interviews, which often included multiple participants per interview. Three of the jails had established routine practices for MOUD administration. Two jails occasionally administered MOUD or had plans in place to be able to administer, while the remaining two did not offer any MOUD. While administrative support, collaborative partnerships, and jail nurses facilitated MOUD use, barriers were more prevalent, including physical space limitations, distance to services, lack of providers in the area, staffing and training issues, funding/budget issues, and perceived risk of diversion.Conclusion Making MOUD available to people who are incarcerated is an important and timely step in enhancing the jail environment, especially in rural areas that often lack access to MOUD. As states look to require MOUD availability for people who are incarcerated, facilitators to MOUD adoption/expansion can be leveraged while strategies are needed to overcome barriers.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Mackey, Katherine
    Veazie, Stephanie
    Anderson, Johanna
    Bourne, Donald
    Peterson, Kim
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 954 - 963
  • [2] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Katherine Mackey
    Stephanie Veazie
    Johanna Anderson
    Donald Bourne
    Kim Peterson
    [J]. Journal of General Internal Medicine, 2020, 35 : 954 - 963
  • [3] Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care
    Tofighi, Babak
    Williams, Arthur Robin
    Chemi, Chemi
    Sindhu, Selena
    Dickson, Vicky
    Lee, Joshua D.
    [J]. SUBSTANCE USE & MISUSE, 2019, 54 (14) : 2409 - 2419
  • [4] Availability of Medications for Opioid Use Disorder in US Jails
    Sufrin, Carolyn
    Kramer, Camille
    Terplan, Mishka
    Fiscella, Kevin
    Olson, Sarah
    Voegtline, Kristin
    Latkin, Carl
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (06) : 1573 - 1575
  • [5] The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails
    Pfaff, Aly
    Cochran, Amy
    Vechinski, Jessi
    Molfenter, Todd
    Zayas-Caban, Gabriel
    [J]. DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 10
  • [6] Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings
    Kelsch, Jordan
    McGladrey, Margaret
    Oser, Carrie
    Booty, Marisa
    Fanucchi, Laura
    Walsh, Sharon
    Lofwall, Michelle
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [7] A Qualitative Study of Barriers and Facilitators to Integrating Medications for Opioid Use Disorder and HIV Preexposure Prophylaxis for Adolescents and Young Adults
    Herrera, Maria Christina
    Darien, Kaja
    Wood, Sarah
    Hadland, Scott E.
    Metzger, David
    Dowshen, Nadia
    [J]. JOURNAL OF ADDICTION MEDICINE, 2023, 17 (06) : E349 - E354
  • [8] Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder
    Fiddian-Green, Alice
    Gubrium, Aline
    Harrington, Calla
    Evans, Elizabeth A.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (15)
  • [9] Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina
    Oros, Sarah M.
    Christon, Lillian M.
    Barth, Kelly S.
    Berini, Carole R.
    Padgett, Bennie L.
    Diaz, Vanessa A.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2021, 56 (01): : 14 - 39
  • [10] MEDICATIONS FOR OPIOID USE DISORDER IN MASSACHUSETTS JAILS: IMPACT ON OVERDOSE DEATHS
    Chatterjee, Avik
    Savinkina, Alexandra
    Macmadu, Alexandria
    Adams, Joella W.
    Walley, Alexander Y.
    Linas, Benjamin
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S121 - S122